TWI724210B - A longan flower extract with anti-aging, whitening, anti-allergic and cell repair - Google Patents
A longan flower extract with anti-aging, whitening, anti-allergic and cell repair Download PDFInfo
- Publication number
- TWI724210B TWI724210B TW106124544A TW106124544A TWI724210B TW I724210 B TWI724210 B TW I724210B TW 106124544 A TW106124544 A TW 106124544A TW 106124544 A TW106124544 A TW 106124544A TW I724210 B TWI724210 B TW I724210B
- Authority
- TW
- Taiwan
- Prior art keywords
- composition
- skin
- longan flower
- inhibit
- activity
- Prior art date
Links
- 235000000235 Euphoria longan Nutrition 0.000 title claims abstract description 63
- 230000008439 repair process Effects 0.000 title claims abstract description 20
- 230000002087 whitening effect Effects 0.000 title claims abstract description 14
- 230000003266 anti-allergic effect Effects 0.000 title claims abstract description 9
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 7
- 239000000284 extract Substances 0.000 title abstract description 47
- 244000139609 Euphoria longan Species 0.000 title 1
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 63
- 210000004027 cell Anatomy 0.000 claims abstract description 37
- 230000000694 effects Effects 0.000 claims abstract description 33
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 21
- 150000003254 radicals Chemical class 0.000 claims abstract description 19
- 210000003491 skin Anatomy 0.000 claims abstract description 18
- 108010003272 Hyaluronate lyase Proteins 0.000 claims abstract description 14
- 102000001974 Hyaluronidases Human genes 0.000 claims abstract description 14
- 102000003820 Lipoxygenases Human genes 0.000 claims abstract description 14
- 108090000128 Lipoxygenases Proteins 0.000 claims abstract description 14
- 229960002773 hyaluronidase Drugs 0.000 claims abstract description 14
- 102000003425 Tyrosinase Human genes 0.000 claims abstract description 13
- 108060008724 Tyrosinase Proteins 0.000 claims abstract description 13
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims abstract description 10
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims abstract description 10
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 claims abstract description 8
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 7
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 7
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 7
- -1 iron ions Chemical class 0.000 claims abstract description 6
- 210000004927 skin cell Anatomy 0.000 claims abstract description 6
- 230000037303 wrinkles Effects 0.000 claims abstract description 5
- 230000037314 wound repair Effects 0.000 claims abstract description 4
- 230000011382 collagen catabolic process Effects 0.000 claims abstract description 3
- 239000000469 ethanolic extract Substances 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 20
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 14
- 231100000277 DNA damage Toxicity 0.000 claims description 11
- 230000008099 melanin synthesis Effects 0.000 claims description 11
- 230000005778 DNA damage Effects 0.000 claims description 10
- 206010061218 Inflammation Diseases 0.000 claims description 8
- 230000005764 inhibitory process Effects 0.000 claims description 8
- 239000003963 antioxidant agent Substances 0.000 claims description 7
- 230000003078 antioxidant effect Effects 0.000 claims description 7
- 230000004054 inflammatory process Effects 0.000 claims description 7
- 235000006708 antioxidants Nutrition 0.000 claims description 6
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 claims description 6
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 5
- 230000003064 anti-oxidating effect Effects 0.000 claims description 5
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 5
- 239000002537 cosmetic Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 claims description 5
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 claims description 3
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 claims description 3
- 239000002778 food additive Substances 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 201000004624 Dermatitis Diseases 0.000 claims description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 2
- 235000013373 food additive Nutrition 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract description 16
- 230000007246 mechanism Effects 0.000 abstract description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052742 iron Inorganic materials 0.000 abstract description 2
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 32
- 238000002474 experimental method Methods 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 102000053187 Glucuronidase Human genes 0.000 description 9
- 108010060309 Glucuronidase Proteins 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 8
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 229920001436 collagen Polymers 0.000 description 8
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- HIYAVKIYRIFSCZ-CYEMHPAKSA-N 5-(methylamino)-2-[[(2S,3R,5R,6S,8R,9R)-3,5,9-trimethyl-2-[(2S)-1-oxo-1-(1H-pyrrol-2-yl)propan-2-yl]-1,7-dioxaspiro[5.5]undecan-8-yl]methyl]-1,3-benzoxazole-4-carboxylic acid Chemical compound O=C([C@@H](C)[C@H]1O[C@@]2([C@@H](C[C@H]1C)C)O[C@@H]([C@@H](CC2)C)CC=1OC2=CC=C(C(=C2N=1)C(O)=O)NC)C1=CC=CN1 HIYAVKIYRIFSCZ-CYEMHPAKSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- HIYAVKIYRIFSCZ-UHFFFAOYSA-N calcium ionophore A23187 Natural products N=1C2=C(C(O)=O)C(NC)=CC=C2OC=1CC(C(CC1)C)OC1(C(CC1C)C)OC1C(C)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-UHFFFAOYSA-N 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 210000003630 histaminocyte Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 230000020520 nucleotide-excision repair Effects 0.000 description 4
- 230000002000 scavenging effect Effects 0.000 description 4
- 230000028937 DNA protection Effects 0.000 description 3
- 230000033616 DNA repair Effects 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 108090001005 Interleukin-6 Proteins 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000005779 cell damage Effects 0.000 description 3
- 208000037887 cell injury Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 231100000263 cytotoxicity test Toxicity 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 102100026802 72 kDa type IV collagenase Human genes 0.000 description 2
- 101710151806 72 kDa type IV collagenase Proteins 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 2
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 2
- 102000013760 Microphthalmia-Associated Transcription Factor Human genes 0.000 description 2
- 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000003364 immunohistochemistry Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229940127554 medical product Drugs 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- GOZMBJCYMQQACI-UHFFFAOYSA-N 6,7-dimethyl-3-[[methyl-[2-[methyl-[[1-[3-(trifluoromethyl)phenyl]indol-3-yl]methyl]amino]ethyl]amino]methyl]chromen-4-one;dihydrochloride Chemical compound Cl.Cl.C=1OC2=CC(C)=C(C)C=C2C(=O)C=1CN(C)CCN(C)CC(C1=CC=CC=C11)=CN1C1=CC=CC(C(F)(F)F)=C1 GOZMBJCYMQQACI-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108030002440 Catalase peroxidases Proteins 0.000 description 1
- 102000000503 Collagen Type II Human genes 0.000 description 1
- 108010041390 Collagen Type II Proteins 0.000 description 1
- 230000007035 DNA breakage Effects 0.000 description 1
- 235000000525 Dimocarpus longan Nutrition 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 101001134060 Homo sapiens Melanocyte-stimulating hormone receptor Proteins 0.000 description 1
- 102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N beta-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- DBLXOVFQHHSKRC-UHFFFAOYSA-N ethanesulfonic acid;2-piperazin-1-ylethanol Chemical compound CCS(O)(=O)=O.OCCN1CCNCC1 DBLXOVFQHHSKRC-UHFFFAOYSA-N 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000006303 immediate early viral mRNA transcription Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 230000008789 oxidative DNA damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Pain & Pain Management (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Birds (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
本發明係有關於一種具有一種具抗老化、美白、抗過敏及細胞修護之龍眼花萃取物,其係將一有效劑量之龍眼花萃取物投予至一皮膚細胞,清除DPPH.及ABTS.+自由基能力、還原力、螯合鐵離子及抑制脂質過氧化物效能;抑制酪胺酸酶活性;清除一氧化氮(NO)自由基、抑制脂氧合酶lipoxygenase-1(LOX-1)活性;抑制玻尿酸酶之能力,提高皮膚玻尿酸含量,促進傷口修復,減少皺紋產生;抑制基質金屬蛋白酶(MMPs)活性,降低膠原蛋白降解;促進細胞修復的能力及提高抗過敏之能力等機制作用。 The present invention relates to a longan flower extract with anti-aging, whitening, anti-allergic and cell repair, which is to administer an effective dose of longan flower extract to a skin cell to remove DPPH. And ABTS. + Free radical ability, reducing power, chelating iron ions and inhibiting lipid peroxides; inhibiting tyrosinase activity; eliminating nitric oxide (NO) free radicals, inhibiting lipoxygenase-1 (LOX-1) Activity; Inhibit the ability of hyaluronidase, increase skin hyaluronic acid content, promote wound repair, reduce wrinkles; inhibit the activity of matrix metalloproteinases (MMPs), reduce collagen degradation; promote cell repair ability and improve anti-allergic ability and other mechanisms.
Description
本發明係有關於一種龍眼花萃取之應用,尤其係指以龍眼花(DLFE)作為化妝品、保養品等皮膚外用品之添加物,以達到抗老化、抗氧化、抗發炎、抑制黑色素、抗皺、抗過敏及細胞修復等機制作用之目的。 The present invention relates to the application of longan flower extract, especially refers to the use of longan flower (DLFE) as an additive for cosmetics, skin care products and other external products to achieve anti-aging, anti-oxidation, anti-inflammation, inhibition of melanin, anti-wrinkle, The purpose of anti-allergic and cell repair mechanisms.
現代的東方人對於白晳的膚色需求日益提高,並且對於健康也同樣的重視,因此如何提出一種健康的淡斑方式對於醫藥外用品產業實是一發展重點。傳統植物針對美容保養,多為一些補氣活血、調整體質的溫補藥物,亦有少許單、複方直接使用於皮膚美白、除痘、消炎等用途。但是對於植物萃取物中之有效成分之機制分析與其於醫藥外用品中之配方設計應用,仍是國內醫藥外用品產業需積極開發的重點。因此如能開發傳統植物成為低劑量、高效能之淡斑產品,將有助於提升醫藥外用品科技產業。 Modern Orientals have an increasing demand for fair complexion, and they also attach the same importance to health. Therefore, how to propose a healthy way to lighten spots is a development focus for the non-medical products industry. Traditional plants are aimed at beauty and maintenance. Most of them are warming and invigorating medicines for invigorating qi, activating blood and adjusting physique. There are also a few single or compound prescriptions that are directly used for skin whitening, acne removal, and anti-inflammatory. However, the analysis of the mechanism of the effective ingredients in plant extracts and their formulation design and application in quasi-medicinal products are still the focus of active development in the domestic quasi-medicine industry. Therefore, if the traditional plants can be developed into low-dose, high-efficiency spot-lightening products, it will help to enhance the technology industry of medical products.
目前發現到的問題是,現有的美白產品裡面,多是藉由維生素C(Vitamin C)、對苯二酚(Hydroquinone)、杜鵑花酸(Acelaic acid)和熊果素(Arbutin)來達到淡斑的功效,雖然這些物質對於淡斑的確有顯著的功效,然而,有些淡斑劑之作用為直接破壞黑色素細胞,因此會造成細 胞的毒殺性。因此抑制黑色素生成與抗氧化成分之安全性與其作用濃度是值得重視的。本發明是萃取出天然植物龍眼花萃取物具有清除DPPH.及ABTS.+自由基能力、還原力、螯合鐵離子及抑制脂質過氧化物效能;抑制酪胺酸酶活性;清除一氧化氮(NO)自由基、抑制脂氧合酶lipoxygenase-1(LOX-1)活性。 The problem found so far is that in the existing whitening products, most of the existing whitening products use vitamin C, hydroquinone, azaleaic acid and arbutin to achieve the effect of reducing spots. Although these substances do have significant effects on blemishes, some blemishes have the effect of directly destroying melanocytes, thus causing cell cytotoxicity. Therefore, the safety and concentration of melanin production and antioxidant components are worthy of attention. The present invention extracts natural plant longan flower extract which can remove DPPH. And ABTS. + Free radical ability, reducing power, chelating iron ions and inhibiting lipid peroxides; inhibiting tyrosinase activity; eliminating nitric oxide (NO) free radicals, inhibiting lipoxygenase-1 (LOX-1) active.
大部分文獻皆指出龍眼花具有抗氧化及抗發炎之功效,但較少有抑制黑色素生合成及DNA修復之活性的相關研究,亦未有其美白及抗老化的功能發現,而市售產品所含之美白成分例如:維生素C(Vitamin C)、對苯二酚(Hydroquinone)、杜鵑花酸(Acelaic acid)和熊果素(Arbutin),雖具有顯著功效,但是有些美白劑之作用為直接破壞黑色素細胞,因此會造成細胞的毒殺性。 Most of the literature points out that longan flower has anti-oxidant and anti-inflammatory effects, but there are few related studies on the activity of inhibiting melanin biosynthesis and DNA repair, and there is no discovery of its whitening and anti-aging functions. It contains whitening ingredients such as Vitamin C, Hydroquinone, Acelaic acid and Arbutin. Although they have significant effects, some whitening agents can directly destroy melanocytes , So it will cause cell toxicity.
發明人即是鑑於上述現有美白、抗老化之產品組合物於實際實施使用時仍具有多處缺失,本於孜孜不倦之精神,藉由其豐富專業知識及多年之實務經驗加以改善,並據此研創出本發明。 In view of the fact that the above-mentioned existing whitening and anti-aging product compositions still have many shortcomings in actual use, based on the tireless spirit, with his rich professional knowledge and years of practical experience to improve, and based on this research Created the present invention.
龍眼花含有大量的多酚類及黃酮類化合物,具有很好的抗氧化能力,且具有降血脂及抑制脂質合成之功效。然而相關文獻討論卻不多見,,因此本發明即以龍眼花萃取物進行一系列抗氧化、DNA修復、抑制黑色素生合成及抗發炎活性評估。 Longan flower contains a lot of polyphenols and flavonoids, which has good antioxidant capacity, and has the effects of lowering blood lipids and inhibiting lipid synthesis. However, relevant literature discussions are rare, so the present invention uses longan flower extract to perform a series of antioxidant, DNA repair, inhibition of melanin biosynthesis and anti-inflammatory activity evaluation.
本發明主要目的為提供一種龍眼花萃取物之應用,其係指以龍眼花(Dimocarpus longan flower,DLF)水萃及乙醇萃取物作為具 有清除自由基能力及抑制酪胺酸酶活性之化妝品添加物;藉此,龍眼花萃取物可作為皮膚外用品以用於預防或緩和一個體的皮膚老化現象,達到抗老化、抗氧化、抗發炎、抑制黑色素、抗皺、抗過敏及細胞修護等機制作用。 The main purpose of the present invention is to provide an application of longan flower extract, which refers to the use of longan flower ( Dimocarpus longan flower , DLF) water and ethanol extracts as cosmetic additives that have the ability to scavenge free radicals and inhibit tyrosinase activity ; In this way, longan flower extract can be used as a skin external product to prevent or alleviate the skin aging of one body, to achieve anti-aging, anti-oxidation, anti-inflammatory, inhibition of melanin, anti-wrinkle, anti-allergic and cell repair and other mechanisms .
為了達到上述實施目的,本發明一種龍眼花萃取物之應用,其係將一有效劑量之龍眼花萃取物投至一皮膚細胞,具清除自由基、抑制脂質過氧化物效能以及抑制脂氧合酶lipoxygenase-1(LOX-1)活性,可提高抗氧化、抑制黑色素生成、抗發炎及細胞修復。 In order to achieve the above-mentioned implementation objectives, the present invention uses a longan flower extract to apply an effective dose of the longan flower extract to a skin cell, which has the effect of scavenging free radicals, inhibiting lipid peroxides, and inhibiting lipoxygenase. The activity of lipoxygenase-1 (LOX-1) can improve anti-oxidation, inhibit melanin production, anti-inflammatory and cell repair.
較佳者,該龍眼花萃取物包含一水萃DLFW及一乙醇萃取物DLFE。 Preferably, the longan flower extract includes a water extract DLFW and an ethanol extract DLFE.
較佳者,該龍眼花萃取物係具有清除或減少自由基以防止細胞老化之能力。 Preferably, the longan flower extract has the ability to scavenge or reduce free radicals to prevent cell aging.
較佳者,該自由基係為DPPH(2,2-diphenyl-1-picrylhydrazyl)自由基或ABTS(2,2-Azino-bis-3-ethylbenzothiazoline-6-sulfonic acid)自由基。 Preferably, the free radical is DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical or ABTS (2,2-Azino-bis-3-ethylbenzothiazoline-6-sulfonic acid) free radical.
較佳者,該龍眼花萃取物係作為美白或抗氧化之化妝材料組成物、食品添加物或醫藥組成物。 Preferably, the longan flower extract is used as a whitening or anti-oxidant cosmetic material composition, food additive or medical composition.
較佳者,該龍眼花萃取物具抑制UV照射引起之皮膚發炎反應或皮膚消炎劑。 Preferably, the longan flower extract can inhibit skin inflammation caused by UV irradiation or a skin anti-inflammatory agent.
較佳者,該龍眼花萃取物係作為抗發炎之化妝材料組成物或醫藥組成物。 Preferably, the longan flower extract is used as an anti-inflammatory cosmetic material composition or medical composition.
較佳者,該龍眼花萃取物具有調節p53及NER修復系統之相關因子來修復由UV照射引起的DNA之損傷。 Preferably, the longan flower extract has factors related to regulating p53 and NER repair system to repair DNA damage caused by UV irradiation.
較佳者,該龍眼花萃取物具有抑制細胞外蘑菇酪胺酸酶之活性,進而降低黑色素生成。 Preferably, the longan flower extract has the activity of inhibiting extracellular mushroom tyrosinase, thereby reducing melanin production.
較佳者,該龍眼花萃取物可抑制NO及LOX-1的活性達到抑制發炎反應。 Preferably, the longan flower extract can inhibit the activity of NO and LOX-1 to inhibit inflammation.
較佳者,該龍眼花萃取物具有抑制玻尿酸酶之能力,提高皮膚玻尿酸含量,促進傷口修復,減少皺紋產生。 Preferably, the longan flower extract has the ability to inhibit hyaluronidase, increase skin hyaluronic acid content, promote wound repair, and reduce wrinkles.
較佳者,該龍眼花萃取物及具有抑制基質金屬蛋白酶(MMPs)活性,降低膠原蛋白降解。 Preferably, the longan flower extract has inhibitory activity of matrix metalloproteinases (MMPs) and reduces collagen degradation.
較佳者,該龍眼花萃取物具有促進細胞修復的能力。 Preferably, the longan flower extract has the ability to promote cell repair.
較佳者,該龍眼花萃取物提高抗過敏之能力。 Preferably, the longan flower extract improves the anti-allergic ability.
圖1係本發明細胞毒理性測試圖。 Figure 1 is a graph of the cytotoxicity test of the present invention.
圖2係本發明清除自由基能力測試圖。 Figure 2 is a test diagram of the free radical scavenging ability of the present invention.
圖3係本發明美白效能測試圖。 Figure 3 is a test chart of the whitening efficacy of the present invention.
圖4係本發明抗發炎試驗圖。 Figure 4 is a graph of the anti-inflammatory test of the present invention.
圖5係本發明DNA保護試驗圖。 Figure 5 is a diagram of the DNA protection test of the present invention.
圖6係本發明DNA保護對照圖。 Figure 6 is a comparison diagram of DNA protection of the present invention.
圖7係本發明抗皺試驗圖。 Figure 7 is a graph of the anti-wrinkle test of the present invention.
圖8係本發明抑制玻尿酸酶能力試驗圖。 Figure 8 is a graph of the present invention's ability to inhibit hyaluronidase.
圖9係本發明細胞之傷口癒合能力試驗圖。 Figure 9 is a graph showing the wound healing ability of the cells of the present invention.
圖10係本發明UVB細胞受損試驗圖。 Figure 10 is a diagram of the UVB cell damage test of the present invention.
圖11係本發明抗敏能力試驗圖。 Figure 11 is a graph of the anti-allergic ability test of the present invention.
本發明之目的及其結構功能上的優點,將依據以下圖面所示之結構,配合具體實施例予以說明,俾使審查委員能對本發明有更深入且具體之瞭解。 The purpose of the present invention and its structural and functional advantages will be described based on the structure shown in the following drawings and specific embodiments, so that the review committee can have a more in-depth and specific understanding of the present invention.
首先,本發明人由龍眼花分離製得一水萃DLFW、一乙醇萃取物DLFE,,上述材料之水萃DLFW及乙醇萃取物DLFE具有降低因H2O2刺激而引起的HaCaT細胞內氧化壓力,提高細胞內glutathione(GSH)含量,及提高抗氧化酵素superoxide dismutase(SOD)、catalase和glutathione peroxidase(GPx)的表現量。 First of all, the inventors prepared monohydrate DLFW and monoethanolic extract DLFE from longan flowers. The water-extracted DLFW and ethanol extract DLFE of the above materials can reduce the oxidative pressure in HaCaT cells caused by H 2 O 2 stimulation. , Increase the content of glutathione (GSH) in cells, and increase the expression of antioxidant enzymes superoxide dismutase (SOD), catalase and glutathione peroxidase (GPx).
龍眼花萃取物(水萃DLFW、乙醇萃取物DLFE)具抑制細胞內酪胺酸酶(tyrosinase)活性及降低黑色素生成量。以免疫螢光試驗及西方墨點法試驗,龍眼花萃取物(水萃DLFW、乙醇萃取物DLFE)作用於細胞後,證實具有抑制黑色素生合成途經中接受器MC1R(melanocortin-lreceptor)和MITF(microphthalmia-associated transcription factor)之表現,並影響酪胺酸酶、TRP-2(tyrosinase-related proteins-2)和TRP-1(tyrosinase-relatedproteins-1)的表現,進而抑制黑色素生成。 Longan flower extract (water extract DLFW, ethanol extract DLFE) can inhibit tyrosinase activity in cells and reduce melanin production. By immunofluorescence test and western ink spot test, after longan flower extract (water extract DLFW, ethanol extract DLFE) acts on the cells, it is confirmed that it can inhibit the melanin biosynthesis process through the receptor MC1R (melanocortin-lreceptor) and MITF ( microphthalmia-associated transcription factor), and affect the performance of tyrosinase, TRP-2 (tyrosinase-related proteins-2) and TRP-1 (tyrosinase-related proteins-1), thereby inhibiting melanin production.
在抗發炎能力試驗中,龍眼花萃取物具抑制細胞內發炎 因子(TNF-α、IL-1β及IL-6)的含量,且具有降低發炎相關路徑的p38、IL-6、IL-1β和TNF-α蛋白質表現。動物試驗SKH-1小鼠經UVB照射後以免疫組織化學染色法immunohistochemistry(IHC)及西方墨點法試驗證實龍眼花萃取物具有降低發炎相關路徑的p38、IL-6、IL-1β和TNF-α蛋白質表現。 In the anti-inflammatory ability test, longan flower extract can inhibit the content of intracellular inflammatory factors (TNF-α, IL-1β and IL-6), and has the p38, IL-6, IL-1β, and IL-1β that reduce inflammation-related pathways. TNF-α protein performance. Animal experiment SKH-1 mice were irradiated with UVB and used immunohistochemistry (IHC) and western blotting methods to confirm that longan flower extract has reduced inflammation-related pathways p38, IL-6, IL-1β and TNF- Alpha protein performance.
在DNA修復及保護能力試驗中,龍眼花萃取物具有調節nucleotideexcision repair(NER)修復系統之相關因子來修復由UV照射引起的DNA之損傷,以及調節p53及NER修復系統之相關因子來修復由UV照射引起之DNA損傷。 In the DNA repair and protection ability test, the longan flower extract has the relevant factors of regulating the nucleotideexcision repair (NER) repair system to repair the DNA damage caused by UV irradiation, and the regulation of p53 and the relevant factors of the NER repair system to repair the damage caused by UV DNA damage caused by irradiation.
藉由下述具體實施例,可進一步證明本發明可實際應用之範圍,但不意欲以任何形式限制本發明之範圍。 The following specific examples can further prove the scope of practical application of the present invention, but it is not intended to limit the scope of the present invention in any form.
實驗一:細胞毒理性測試 Experiment 1: Cytotoxicity test
鑑於現有之美白劑或皮膚黑色素抑制劑之作用為會造成細胞毒性,因此本發明人於取得此龍眼花萃取物後,先進行此化合物之細胞毒殺測試實驗,利用100、250和500μg/ml濃度之龍眼花萃取物作用於HaCaT細胞24小時之後,利用MTT試驗測定其存活度。其結果如圖1所示,龍眼花之水萃DLFW及乙醇萃取物DLFE在細胞中不具毒性,與市售常用成分ascorbic acid(AA)相比來的安全。 In view of the fact that the existing whitening agents or skin melanin inhibitors can cause cytotoxicity, the inventors first performed the cytotoxicity test experiment of this compound after obtaining this longan flower extract, using 100, 250 and 500 μg/ml concentrations After the longan flower extract was applied to HaCaT cells for 24 hours, the survival rate was measured by MTT test. The results are shown in Figure 1. Longan Flower Water Extract DLFW and ethanol extract DLFE are not toxic in cells, and are safer compared to the commonly used ingredient ascorbic acid (AA) in the market.
實驗二:清除自由基能力測試 Experiment 2: Test of the ability to scavenge free radicals
本實驗探討龍眼花之水萃DLFW、乙醇萃取物DLFE清除自由基的功效,利用DPPH.和ABTS+.兩種自由基測試其清除能力,其結果如圖2所示, 乙醇萃取物DLFE在清除DPPH自由基試驗中約在45μg/ml時就達到50%的清除率,且乙醇萃取物DLFE清除兩種自由基的能力更優於水萃DLFW,其結果顯示龍眼花萃取物對於兩種自由基有很好的抑制率。 This experiment explores the effect of longan flower water extract DLFW and ethanol extract DLFE in scavenging free radicals, using DPPH. And ABTS+. The scavenging ability of two free radicals was tested, and the results are shown in Figure 2. The ethanol extract DLFE reached a scavenging rate of 50% at about 45μg/ml in the DPPH free radical scavenging test, and the ethanol extract DLFE scavenged both The ability of free radicals is better than that of water extraction DLFW, and the results show that longan flower extract has a good inhibition rate for two free radicals.
實驗三:美白效能測試 Experiment 3: Whitening efficacy test
酪胺酸酶為黑色素生合成途徑中重要的酵素,將龍眼花之水萃DLFW及乙醇萃取物DLFE以不同濃度100、250和500μg/ml進行細胞外蘑菇酪胺酸酶活性試驗評估。其結果如圖3所示,經過龍眼花之水萃DLFW及乙醇萃取物DLFE作用後,抑制細胞外蘑菇酪胺酸酶活性隨濃度增加而提高,且乙醇萃取物DLFE(EC50為410μg/ml)的抑制率優於水萃DLFW(EC50為624μg/ml),證實龍眼花萃取物具有抑制細胞外蘑菇酪胺酸酶之活性。 Tyrosinase is an important enzyme in the biosynthesis pathway of melanin. The water-extracted DLFW of longan flower and the ethanol extract DLFE were tested for extracellular mushroom tyrosinase activity at different concentrations of 100, 250 and 500 μg/ml. The results are shown in Figure 3. After the action of DLFW and ethanol extract of longan flower, the activity of inhibiting extracellular mushroom tyrosinase increases with the increase of concentration, and the ethanol extract of DLFE (EC 50 is 410μg/ml The inhibition rate of) is better than that of water-extracted DLFW (EC 50 is 624μg/ml), which proves that longan flower extract has the activity of inhibiting extracellular mushroom tyrosinase.
實驗四:抗發炎試驗 Experiment 4: Anti-inflammatory test
NO為主要參與發炎反應的介質之一,而LOX-1是最常見引起發炎反應的酵素,藉由此試驗評估龍眼花之水萃DLFW及乙醇萃取物DLFE抗發炎效果。其結果如圖4所示,龍眼花之水萃DLFW及乙醇萃取物DLFE,有不錯的清除NO自由基的能力及抑制LOX-1活性,證實龍眼花之水萃DLFW及乙醇萃取物DLFE能經由抑制NO及LOX-1的活性來達到抑制發炎反應的活性,具有抗發炎之效果。 NO is one of the main mediators involved in inflammation, and LOX-1 is the most common enzyme that causes inflammation. This test evaluates the anti-inflammatory effects of longan flower water extract DLFW and ethanol extract DLFE. The results are shown in Figure 4. Longan flower water extract DLFW and ethanol extract DLFE have a good ability to scavenge NO free radicals and inhibit the activity of LOX-1, which proves that Longan flower water extract DLFW and ethanol extract DLFE can pass Inhibit the activity of NO and LOX-1 to achieve the activity of inhibiting the inflammatory response, and has an anti-inflammatory effect.
實驗五:DNA保護試驗 Experiment 5: DNA protection test
紫外線曝曬或生理代謝,均會增加氧化壓力造成DNA的損傷。本試驗以pUC119 DNA以H2O2(1mM)誘導及以UVB(20mJ/cm2)照射,引發DNA 損傷,評估龍眼花之水萃DLFW及乙醇萃取物DLFE是否具有保護DNA避免因氧化壓力及UVB照射所造成的DNA損傷。請參照圖5,pUC119 DNA原為超螺旋體結構(Supercoiled form,SC-form),經H2O2(1mM)誘導及UVB(20mJ/cm2)照射後會造成DNA斷裂,形成(Linear form,L-form)和(Open form,O-form)之DNA片段。續參照圖6,當加入不同濃度之乙醇萃取物DLFE(100、250和500μg/ml)再以H2O2誘導及UVB照射後,結果顯示乙醇萃取物DLFE能有效保護DNA,且隨濃度的增加保護效果越佳,證實龍眼花有保護DNA免於因氧化壓力及UVB照射所造成的損傷。 UV exposure or physiological metabolism will increase oxidative stress and cause DNA damage. In this test, pUC119 DNA was induced with H 2 O 2 (1mM) and irradiated with UVB (20mJ/cm 2 ) to cause DNA damage. To evaluate whether the water extract of longan flower DLFW and ethanol extract DLFE can protect DNA from oxidative stress and DNA damage caused by UVB radiation. Please refer to Figure 5, pUC119 DNA was originally a supercoiled form (SC-form). After H 2 O 2 (1mM) induction and UVB (20mJ/cm 2 ) irradiation, it will cause DNA breakage and form (Linear form, L-form) and (Open form, O-form) DNA fragments. Continuing to refer to Figure 6, when different concentrations of ethanol extract DLFE (100, 250 and 500μg/ml) are added and then induced by H 2 O 2 and UVB irradiated, the results show that the ethanol extract DLFE can effectively protect DNA, and the concentration of The better the protection effect is, it is proved that longan flower can protect DNA from damage caused by oxidative stress and UVB irradiation.
實驗六:抗皺試驗 Experiment 6: Anti-wrinkle test
膠原蛋白主要存在於皮膚組織中真皮層的結締組織中,是人體內含量最高的蛋白質,有很強的伸展力且能支撐真皮層整體結構,膠原蛋白也是細胞外基質的主要組成成分,保持皮膚彈性並具有修復之能力,而膠原蛋白會隨著老化及環境等因素而流失,使皮膚產生皺紋及骨質疏鬆等問題。其中基質金屬蛋白酶(Matrix metalloproteinases,MMPs)為膠原蛋白分解酵素,MMP-2及MMP-9主要是分解第II型膠原蛋白。為調節光老化重要因子,纖維母細胞受UV曝曬會引起基質金屬蛋白酶大量表現,進而降解細胞外基質(ECM)使真皮組織的膠原蛋白降解。 Collagen mainly exists in the connective tissue of the dermis in the skin tissue. It is the highest protein content in the human body. It has a strong stretching force and can support the overall structure of the dermis. Collagen is also the main component of the extracellular matrix to maintain the skin. It is elastic and has the ability to repair, and collagen will be lost with aging and environmental factors, causing wrinkles and osteoporosis in the skin. Among them, matrix metalloproteinases (MMPs) are collagen degrading enzymes, and MMP-2 and MMP-9 mainly decompose type II collagen. In order to adjust the important factors of photoaging, UV exposure of fibroblasts will cause a large number of matrix metalloproteinases to degrade the extracellular matrix (ECM) and degrade the collagen of the dermal tissue.
本試驗將龍眼花之乙醇萃取物DLFE(100、250和500μg/ml)以不同濃度作用於Hs68細胞中培養72小時後,測定膠原蛋白含量。藉此試驗評估該龍眼花之乙醇萃取物DLFE是否具有抑制MMPs之 活性。其結果如圖7所示,經龍眼花之乙醇萃取物DLFE作用後,與Control相比,膠原蛋白含量隨著濃度提高而增加,因此可推知龍眼花之乙醇萃取物DLFE具有抑制MMP-9及MMP-2之活性,並可以有效的增加纖維母細胞生成膠原蛋白之含量。 In this experiment, the ethanol extract DLFE (100, 250 and 500μg/ml) of longan flower was treated in Hs68 cells at different concentrations and cultured for 72 hours to determine the collagen content. This test evaluates whether the ethanol extract DLFE of Longan flower has the activity of inhibiting MMPs. The results are shown in Figure 7. After the action of the ethanol extract of longan flower DLFE, compared with Control, the collagen content increased with the increase in concentration. Therefore, it can be inferred that the ethanol extract of longan flower DLFE can inhibit MMP-9 and The activity of MMP-2 can effectively increase the content of collagen produced by fibroblasts.
實驗七:抑制玻尿酸酶能力試驗 Experiment 7: Test of the ability to inhibit hyaluronidase
玻尿酸存在於人體皮膚組織中的真皮層及結締組織中,減少皺紋的產生,並具有促進傷口修復之功效,而玻尿酸酶是一種會使玻尿酸降解的酵素,使玻尿酸的結構瓦解,喪失原有功能。藉由此試驗評估龍眼花之乙醇萃取物DLFE抑制玻尿酸酶之能力。 Hyaluronic acid is present in the dermis and connective tissues of human skin tissues, reducing wrinkles and promoting wound repair. Hyaluronidase is an enzyme that degrades hyaluronic acid, disintegrating the structure of hyaluronic acid and losing its original function. . Through this test, the ethanol extract of longan flower DLFE was evaluated for its ability to inhibit hyaluronidase.
將龍眼花之乙醇萃取物DLFE(500μg/ml)及標準品表沒食子兒茶素(Epigallocatechin gallate,EGCG),分別加入玻尿酸酶(3000unit/mL)作用18小時,結果如圖8所示,經過龍眼花之乙醇萃取物DLFE作用後的位置和Control相比顏色明顯深了許多,顯示DLFE可以有效防止玻尿酸被玻尿酸酶分解,經定量分析出龍眼花之乙醇萃取物DLFE對玻尿酸酶活性之抑制率為82%。結果證實,龍眼花之乙醇萃取物DLFE具有抑制玻尿酸酶活性之能力。 The ethanol extract of longan flower DLFE (500μg/ml) and the standard epigallocatechin (EGCG) were added to hyaluronidase (3000unit/mL) for 18 hours. The results are shown in Figure 8. The position of the ethanol extract of longan flower DLFE is much darker than that of Control, showing that DLFE can effectively prevent hyaluronic acid from being decomposed by hyaluronidase. Quantitative analysis shows that the ethanol extract of longan flower DLFE inhibits hyaluronidase activity The rate is 82%. The results confirmed that the ethanol extract of longan flower DLFE has the ability to inhibit the activity of hyaluronidase.
實驗八:細胞之傷口癒合能力試驗 Experiment 8: Cell wound healing ability test
以傷口癒合(wound healing)試驗評估DLFE是否具有促進細胞修復之能力。首先以龍眼花萃取物DLFE(500μg/ml)作用於HaCaT細胞4小時後,抽乾培養液,以UVB(50mJ/cm2)照射,再加入DLFE作用,培養4小時後,以顯微鏡觀察細胞移動之變化。 The wound healing test is used to evaluate whether DLFE has the ability to promote cell repair. First, Longan flower extract DLFE (500μg/ml) was applied to HaCaT cells for 4 hours, then the culture medium was drained, irradiated with UVB (50mJ/cm 2 ), and DLFE was added. After culturing for 4 hours, observe the cell movement with a microscope The change.
結果如圖9所示,Control及單純照射UVB的細胞沒有太大的移動變化,尤其是單純照射UVB的細胞,從0至48小時幾乎沒有變化。經龍眼花萃取物DLFE作用後之細胞在12小時後有明顯的向中間移動的趨勢,到了48小時已經沒有縫隙。結果再次證實,龍眼花萃取物DLFE具有促進細胞修復的能力。 The results are shown in Fig. 9. The control and the cells irradiated with UVB alone did not change much, especially the cells irradiated with UVB alone, there was almost no change from 0 to 48 hours. The cells after longan flower extract DLFE had a clear tendency to move to the middle after 12 hours, and there were no gaps in 48 hours. The results once again confirmed that the longan flower extract DLFE has the ability to promote cell repair.
實驗九:UVB細胞受損試驗 Experiment 9: UVB cell damage test
彗星試驗是以膠體電泳並以EtBr進行細胞核之染色,偵測單一細胞中DNA經UVB照射後之損傷程度。以DLFE(500μg/ml)作用於HaCaT細胞4小時後,抽乾培養液,以UVB(50mJ/cm2)照射,再加入龍眼花萃取物DLFE作用,培養4小時後,以顯微鏡觀察細胞之損傷程度。 Comet test is a method of gel electrophoresis and staining of cell nucleus with EtBr to detect the damage degree of DNA in a single cell after UVB irradiation. After acting on HaCaT cells with DLFE (500μg/ml) for 4 hours, drain the culture medium, irradiate it with UVB (50mJ/cm 2 ), and add longan flower extract DLFE. After culturing for 4 hours, observe the cell damage with a microscope degree.
結果如圖10所示,單純受UVB照射之細胞,DNA受損且有明顯的拖尾現象,1000顆細胞中,約有50%顆細胞之DNA有受損之情形。經過DLFE作用過後之細胞,在高濃度500μg/ml作用下,1000顆細胞中,約有8%顆細胞之DNA有受損之情形。藉此判斷DLFE具有保護DNA免於UVB照射所造成的傷害。 The results are shown in Figure 10. Cells irradiated by UVB alone have DNA damage and obvious tailing. Among 1,000 cells, about 50% of cells have DNA damage. After DLFE treatment, under the action of a high concentration of 500μg/ml, about 8% of the cells have DNA damage. It can be judged that DLFE can protect DNA from damage caused by UVB radiation.
CPD為DNA受UVB照射後所產生的光產物,結果如圖10所示,經UVB(50mJ/cm2)照射後之細胞,CPD的螢光表現量增加,而經過DLFE(500μg/ml)作用後,明顯降低了UVB光產物的生成,再次證實DLFE具有保護DNA並降低因UVB照射所造成的DNA損傷。 CPD is the light product produced by DNA after UVB irradiation. The results are shown in Figure 10. After UVB (50mJ/cm 2 ) irradiation, the fluorescence of CPD increases, and after DLFE (500μg/ml) After that, the generation of UVB photoproducts was significantly reduced, and it was again confirmed that DLFE can protect DNA and reduce DNA damage caused by UVB irradiation.
實驗十:抗敏能力試驗 Experiment 10: Anti-allergy test
請參照圖11以卡西霉素A23187或抗原誘導之β-葡萄糖醛酸酶去顆粒試 驗:以卡西霉素A23187和抗原誘導RBL-2H3肥大細胞去顆粒的程度,是由β-葡萄糖醛酸酶釋放試驗,經由下列方式改良的方法來測定:接種RBL-2H3肥大細胞(2×104cells/well)在96孔微量盤和RBL-2H3肥大細胞(3×104cells/well)在48孔微量盤中,分別供給卡西霉素A23187誘導實驗和抗原誘導實驗所用,在細胞中加入各種濃度的樣品,靜置20小時;使用迪皮質醇(10nM)作為正對照組。在抗原誘導實驗中,細胞首先以抗-二硝基苯酚IgE單克隆抗體(anti-dinitrophenol IgE,anti-DNP IgE)(5μg/mL)被動高敏至少2小時,將細胞以預熱的台羅德氏緩衝液(135mM氯化鈉,5mM氯化鉀,1.8mM氯化鈣,1.0mM氯化鎂,5.6mM葡萄糖,20mM 4-羥乙基呱嗪乙磺酸,pH 7.4)徹底沖洗後,各別以台羅德氏緩衝液配製的鈣離子載體A23187(卡西霉素,1μM)或抗原二硝基苯-胎牛血清共軛物(100ng/mL)刺激一小時。為測量β-葡萄糖醛酸酶釋放的總量,將未受刺激的細胞以0.5%的Triton X-100溶液裂解,或者不進行處理使細胞自發性的釋放β-葡萄糖醛酸酶;分裝上清液(50μL)與等量的1μM聚氮-乙醯葡萄糖胺(抗原)配製於0.1M檸檬酸鹽緩衝液(pH 4.5)中,用作釋放β-葡萄糖醛酸酶的基底。在37℃下培養1小時後,加入100μL的終止緩衝液(0.1M Na2/NaHCO3,pH 10.0)猝滅反應。將微量盤分析儀(Multiskan Ascent,Thermo Scientific)設定在405nm波長,測量吸光度;β-葡萄糖醛酸酶釋放的抑制百分比是實驗組除以對照值(未處理細胞)的百分比來計算;對二甲基亞碸最大的耐受劑量為0.5%,且所有實驗重複三次。 Please refer to Figure 11: β-glucuronidase degranulation test induced by carbamicin A23187 or antigen: The degree of degranulation of RBL-2H3 mast cells induced by carbamicin A23187 and antigen is determined by β-glucuronic acid The enzyme release test is determined by the following modified method: inoculate RBL-2H3 mast cells (2×10 4 cells/well) in 96-well microplates and RBL-2H3 mast cells (3×10 4 cells/well) in 48 The well microplates were supplied for the carbamicin A23187 induction experiment and the antigen induction experiment respectively. Various concentrations of samples were added to the cells and allowed to stand for 20 hours; cortisol (10 nM) was used as a positive control group. In the antigen induction experiment, the cells were first passively hypersensitized with anti-dinitrophenol IgE (anti-DNP IgE) (5μg/mL) for at least 2 hours. Buffer (135mM sodium chloride, 5mM potassium chloride, 1.8mM calcium chloride, 1.0mM magnesium chloride, 5.6mM glucose, 20mM 4-hydroxyethylpiperazine ethanesulfonic acid, pH 7.4) after thorough washing, each with Calcium ionophore A23187 (carbamicin, 1 μM) or antigen dinitrobenzene-fetal bovine serum conjugate (100ng/mL) prepared in Tyrode’s buffer was stimulated for one hour. In order to measure the total amount of β-glucuronidase released, unstimulated cells were lysed with 0.5% Triton X-100 solution, or the cells were not treated to release β-glucuronidase spontaneously; The clear solution (50 μL) and an equal amount of 1 μM polyazide-acetylglucosamine (antigen) were prepared in 0.1M citrate buffer (pH 4.5) to be used as a substrate for releasing β-glucuronidase. After incubating at 37°C for 1 hour, 100 μL of stop buffer (0.1M Na 2 /NaHCO 3 , pH 10.0) was added to quench the reaction. The microdisc analyzer (Multiskan Ascent, Thermo Scientific) was set to 405nm wavelength, and the absorbance was measured; the inhibition percentage of β-glucuronidase release was calculated by dividing the experimental group by the percentage of the control value (untreated cells); The maximum tolerated dose of Giatosine was 0.5%, and all experiments were repeated three times.
樣品誘導之β-葡萄糖醛酸酶直接去顆粒試驗:在RBL-2H3肥大細胞中,由樣品引發的β-葡萄糖醛酸酶的釋放量是以改良過的β-葡萄糖醛酸酶釋放實驗來決定;簡單地說,將RBL-2H3肥大細胞(4×104cells/well)接種於48孔微量盤中,加入樣品後靜置10小時。將台羅德氏緩衝液加入5.6mM葡萄糖、2mg/mL牛血清白蛋白(BSA)和2mM谷氨酸以製備樣品和細胞所用。50μL的上清液轉移至96孔微量盤,依照前述方式測量β-葡萄糖醛酸酶的釋放量,卡西霉素A23187(1μM)做為正對照組,所有實驗進行重複三次以上。 Sample-induced β-glucuronidase direct degranulation test: In RBL-2H3 mast cells, the amount of β-glucuronidase released by the sample is determined by the modified β-glucuronidase release test ; Simply put, the RBL-2H3 mast cells (4×104cells/well) were seeded in a 48-well microplate, and the sample was added and then allowed to stand for 10 hours. Tyrode's buffer was added to 5.6mM glucose, 2mg/mL bovine serum albumin (BSA) and 2mM glutamic acid to prepare samples and cells. 50 μL of supernatant was transferred to a 96-well microplate, and the amount of β-glucuronidase released was measured according to the aforementioned method. Carximycin A23187 (1 μM) was used as the positive control group. All experiments were repeated more than three times.
綜上所述,本發明證實龍眼花之水萃DLFW及乙醇萃取物DLFE具有清除活性氧和抑制黑色素生成,並具有皮膚表皮細胞之DNA保護、修復能力以及具有抑制發炎反應的產生,具發展成為美白、抗氧化及抗發炎的保養品或保健食品添加劑的潛力,並確能藉由上述所揭露之實施例,達到所預期之使用功效,且本發明亦未曾公開於申請前,誠已完全符合專利法之規定與要求。爰依法提出發明專利之申請,懇請惠予審查,並賜准專利,則實感德便。 In summary, the present invention proves that the water extract of longan flower DLFW and the ethanol extract DLFE have the ability to remove active oxygen and inhibit melanin production, and have the ability to protect and repair the DNA of skin epidermal cells and inhibit the production of inflammation. The potential of skin care products or health food additives for whitening, anti-oxidation and anti-inflammatory, and the expected use effects can be achieved through the embodiments disclosed above, and the present invention has not been disclosed before the application. The provisions and requirements of the Patent Law. If you file an application for a patent for invention in accordance with the law, you are kindly requested to review and grant a quasi-patent.
惟,上述所揭之圖示及說明,僅為本發明之較佳實施例,非為限定本發明之保護範圍;大凡熟悉該項技藝之人士,其所依本發明之特徵範疇,所作之其它等效變化或修飾,皆應視為不脫離本發明之設計範疇。 However, the above-mentioned illustrations and descriptions are only preferred embodiments of the present invention, and are not intended to limit the scope of protection of the present invention. Anyone familiar with the art will do other things based on the characteristic scope of the present invention. Equivalent changes or modifications should be regarded as not departing from the design scope of the present invention.
Claims (9)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW106124544A TWI724210B (en) | 2017-07-21 | 2017-07-21 | A longan flower extract with anti-aging, whitening, anti-allergic and cell repair |
| CN201810751433.9A CN109276493B (en) | 2017-07-21 | 2018-07-10 | Longan flower extract with anti-aging, whitening, anti-allergic and cell repairing functions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW106124544A TWI724210B (en) | 2017-07-21 | 2017-07-21 | A longan flower extract with anti-aging, whitening, anti-allergic and cell repair |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201907944A TW201907944A (en) | 2019-03-01 |
| TWI724210B true TWI724210B (en) | 2021-04-11 |
Family
ID=65185598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW106124544A TWI724210B (en) | 2017-07-21 | 2017-07-21 | A longan flower extract with anti-aging, whitening, anti-allergic and cell repair |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN109276493B (en) |
| TW (1) | TWI724210B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI803146B (en) * | 2022-01-11 | 2023-05-21 | 捷康生技有限公司 | Use of longan flower extract for increasing melatonin in individuals |
| TWI835432B (en) * | 2022-11-28 | 2024-03-11 | 捷康生技有限公司 | USE OF LONGAN FLOWER EXTRACT FOR INHIBITION OF β-GALACTOSIDASE ACTIVITY OF STEM CELL AND PROMOTING SKIN HEALTH |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107137307A (en) * | 2017-05-09 | 2017-09-08 | 江西中医药大学 | A kind of anti-oxidant lightening compositions containing opc |
-
2017
- 2017-07-21 TW TW106124544A patent/TWI724210B/en active
-
2018
- 2018-07-10 CN CN201810751433.9A patent/CN109276493B/en active Active
Non-Patent Citations (7)
| Title |
|---|
| Br J Nutr. 2014 Aug 14;112(3):358-68 |
| http://mypaper.pchome.com.tw/yes5902576/post/1326081148,2010年8月27日 |
| Toxicol Sci. 2006 May;91(1):123-31 |
| 評估台灣產龍眼花萃取液添加於化粧品之研發,黃璿庭,嘉南藥理科技大學化妝品科技研究所,2011 |
| 評估台灣產龍眼花萃取液添加於化粧品之研發,黃璿庭,嘉南藥理科技大學化妝品科技研究所,2011 http://mypaper.pchome.com.tw/yes5902576/post/1326081148,2010年8月27日 龍眼花萃取物抗氧化性之探討,沈宜蓁,國立臺灣大學食品科技研究所,2005 龍眼花抗氧化成分之研究,謝孟潔,國立臺灣大學食品科技研究所,2006 Br J Nutr. 2014 Aug 14;112(3):358-68 Toxicol Sci. 2006 May;91(1):123-31 * |
| 龍眼花抗氧化成分之研究,謝孟潔,國立臺灣大學食品科技研究所,2006 |
| 龍眼花萃取物抗氧化性之探討,沈宜蓁,國立臺灣大學食品科技研究所,2005 |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201907944A (en) | 2019-03-01 |
| CN109276493A (en) | 2019-01-29 |
| CN109276493B (en) | 2022-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yang et al. | Dietary enzyme-treated Hibiscus syriacus L. protects skin against chronic UVB-induced photoaging via enhancement of skin hydration and collagen synthesis | |
| Lu et al. | Succinoglycan riclin relieves UVB-induced skin injury with anti-oxidant and anti-inflammatory properties | |
| JP7016171B2 (en) | Saxifraga extract for cosmetic or therapeutic applications on the skin | |
| Mansoor et al. | Plants with cosmetic uses | |
| Wargala et al. | Snail mucus as an innovative ingredient used in the cosmetology and medical industry | |
| KR20100128733A (en) | Skin external preparation composition containing polysaccharide polysaccharide | |
| KR102289551B1 (en) | A skin-care agent containing hyaluronic acid complex | |
| JP2025517588A (en) | Composition containing Matsutake extract having anti-aging effect and use thereof | |
| US9839604B1 (en) | Composition for an anti-aging treatment | |
| TWI691340B (en) | Red quinoa extract with anti-aging, whitening, anti-allergy and cell repair | |
| TWI724210B (en) | A longan flower extract with anti-aging, whitening, anti-allergic and cell repair | |
| CN104922008A (en) | Essence capable of removing color spots | |
| CN103494737A (en) | Cosmetic preparation using ginger flower as anti-ageing and skin-protecting factor and preparation method of cosmetic preparation | |
| KR100971655B1 (en) | Cosmetic composition having antioxidant, anti-inflammatory and anti-wrinkle effect | |
| CN113693966B (en) | Whitening spot-lightening and brightening cream and preparation method thereof | |
| Wineman et al. | Photo‐damage protective effect of two facial products, containing a unique complex of Dead Sea minerals and Himalayan actives | |
| CN109431824B (en) | Antibacterial deodorizing gel and application thereof | |
| CN108938511B (en) | Composition of natural plant extracts and application of composition in skin moisturizing and acne removing products | |
| KR20140081138A (en) | A skin-care agent containig Antrodia camphorata fruit body extract or Antrodia camphorata mycelium extract | |
| CN115429738B (en) | A kind of anti-acne, repairing and revitalizing essence and preparation method thereof | |
| KR102475898B1 (en) | Cosmetic composition comprising Graviola antibiotic extract and method of preparing the same | |
| CN118236288A (en) | Sun-proof skin care product and preparation method thereof | |
| KR20140081137A (en) | A skin-care agent containig Morchella esculenta fruit body extract or Morchella esculenta mycelium extract | |
| JP2024504330A (en) | Extracts of the top growth of holy basil and cosmetic or dermatological compositions containing the same | |
| RU2806599C1 (en) | Cosmetic composition with anti-aging activity to prevent aging and correct age-related changes in skin, its use (options) |